(Q43542643)

24 November 2017

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy (English)

1 reference

24 November 2017

1 reference

metastatic breast cancer

1 reference

M Ryberg

1

1 reference

24 November 2017

D Nielsen

2

1 reference

24 November 2017

K Osterlind

3

1 reference

24 November 2017

T Skovsgaard

4

1 reference

24 November 2017

P Dombernowsky

5

1 reference

24 November 2017

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

12

1 reference

24 November 2017

81-87

1 reference

24 November 2017

1

1 reference

Survival after first recurrence of breast cancer. The Miami experience

24 November 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Multivariate analysis of prognostic factors in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Survival after first recurrence in breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Influence of age on the metastatic behavior of breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Factors predicting late mortality from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Age as a prognostic factor in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008384019411

7 January 2021

Identifiers

DOI

10.1023/A:1008384019411

1 reference

24 November 2017

1 reference